SILVERARC CAPITAL MANAGEMENT, LLC
Adviser information for SILVERARC CAPITAL MANAGEMENT, LLC last updated from Form ADV on March 25th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 7 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 5 | $538.7M |
Non-Discretionary | 0 | $0 |
Total | 5 | $538.7M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $354.6M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 2 | $184.1M |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 30 |
Services
Advisory Services | Portfolio management for pooled investment vehiclesPortfolio management for businesses or institutional clients |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
20 PARK PLAZASUITE 1116
BOSTON
MA
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 617-284-6952, Fax: None
Websites
Chief Compliance Officer
ANDREW TIMPSON
CHIEF OPERATING OFFICER
20 PARK PLAZA
4TH FLOOR
BOSTON
MA
United States
Tel:
617-284-6952
A*****@*******************M
(Full email address available in API data)
Industry Affiliates
SILVERARC CAPITAL, LLC | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
SILVERARC CAPITAL ALPHA FUND I, L.P. | Hedge Fund | $24.5M | $0.3M | 24 |
SILVERARC CAPITAL ALPHA FUND II, L.P. | Hedge Fund | $456.6M | $1.0M | 81 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
GANDHI, DEVESH, SHARAD | Individual | – | FOUNDER & PRESIDENT | 04/2019 | > 75% |
TIMPSON, ANDREW, JOSEPH | Individual | – | CHIEF OPERATING OFFICER & CHIEF COMPLIANCE OFFICER | 07/2019 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
89BIO INC | COM | 739K | 92K | – |
ABIVAX SA | SPONSORED ADS | 6M | 456K | – |
ADC THERAPEUTICS SA | SHS | 6M | 2M | – |
AKERO THERAPEUTICS INC | COM | 15M | 625K | – |
ALIGOS THERAPEUTICS INC | COM | 229K | 656K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 9M | 36K | – |
ALX ONCOLOGY HLDGS INC | PUT | 1M | 168K | – |
AVIDITY BIOSCIENCES INC | COM | 21M | 518K | – |
BIODESIX INC | COM | 3M | 2M | – |
BIOGEN INC | COM | 4M | 19K | – |
BIOHAVEN LTD | COM | 3M | 100K | – |
C4 THERAPEUTICS INC | COM STK | 7M | 1M | – |
C4 THERAPEUTICS INC | CALL | 693K | 150K | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 14M | 375K | – |
CERUS CORP | COM | 3M | 1M | – |
COGENT BIOSCIENCES INC | COM | 10M | 1M | – |
COMPUGEN LTD | ORD | 3M | 2M | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 8M | 172K | – |
DISC MEDICINE INC | COM | 5M | 101K | – |
ELUTIA INC | CL A COM | 8M | 2M | – |
ENGENE HOLDINGS INC | COM | 2M | 264K | – |
ERASCA INC | COM | 18M | 8M | – |
EVOGENE LTD | SHS | 2M | 3M | – |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 870K | 100K | – |
FRACTYL HEALTH INC | COM | 712K | 167K | – |
FULCRUM THERAPEUTICS INC | COM | 2M | 398K | – |
GERON CORP | COM | 4M | 999K | – |
GOSSAMER BIO INC | COM | 5M | 6M | – |
HELIX ACQUISITION CORP II | CL A ORD SHS | 5M | 500K | – |
INSMED INC | COM PAR $.01 | 9M | 140K | – |
INSMED INC | CALL | 17M | 250K | – |
INTRA-CELLULAR THERAPIES INC | COM | 13M | 192K | – |
JASPER THERAPEUTICS INC | COM NEW | 2M | 110K | – |
KALVISTA PHARMACEUTICALS INC | COM | 7M | 561K | – |
KARYOPHARM THERAPEUTICS INC | COM | 485K | 558K | – |
KODIAK SCIENCES INC | COM | 2M | 1M | – |
LONGBOARD PHARMACEUTICALS IN | COM | 3M | 123K | – |
MACROGENICS INC | COM | 2M | 370K | – |
MERSANA THERAPEUTICS INC | COM | 5M | 3M | – |
MERSANA THERAPEUTICS INC | CALL | 338K | 168K | – |
MERUS N V | COM | 37M | 624K | – |
MIRUM PHARMACEUTICALS INC | COM | 3M | 79K | – |
MODULAR MED INC | COM NEW | 1M | 900K | – |
MOLECULAR TEMPLATES INC | COM NEW | 717K | 624K | – |
MORPHIC HLDG INC | COM | 17M | 486K | – |
NUVALENT INC | COM | 35M | 466K | – |
OLEMA PHARMACEUTICALS INC | COM | 6M | 547K | – |
ORIC PHARMACEUTICALS INC | COM | 8M | 1M | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 3M | 260K | – |
POSEIDA THERAPEUTICS INC | COM | 11M | 4M | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 3M | 67K | – |
RELMADA THERAPEUTICS INC | COM | 298K | 99K | – |
RHYTHM PHARMACEUTICALS INC | COM | 8M | 185K | – |
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 6K | 105K | – |
SAREPTA THERAPEUTICS INC | COM | 7M | 42K | – |
SOLENO THERAPEUTICS INC | COM | 612K | 15K | – |
SOLID BIOSCIENCES INC | COM NEW | 3M | 473K | – |
STOKE THERAPEUTICS INC | COM | 2M | 142K | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 3M | 71K | – |
SYNDAX PHARMACEUTICALS INC | COM | 8M | 370K | – |
TARSUS PHARMACEUTICALS INC | COM | 1M | 40K | – |
TELA BIO INC | COM | 5M | 1M | – |
TREVI THERAPEUTICS INC | COM | 3M | 844K | – |
UROGEN PHARMA LTD | COM | 18M | 1M | – |
VAXCYTE INC | COM | 189K | 3K | – |
VERACYTE INC | COM | 6M | 282K | – |
VERONA PHARMA PLC | SPONSORED ADS | 4M | 305K | – |
VYNE THERAPEUTICS INC | COM | 921K | 467K | – |
WAVE LIFE SCIENCES LTD | SHS | 2M | 495K | – |
ZURA BIO LTD | CLASS A ORD SHS | 1M | 329K | – |